Financial Summary (All financials)
| In millions of JPY, except per share items | Mar-31-22 | Mar-31-21 | Mar-31-20 | Mar-31-19 | Mar-31-18 | Mar-31-17 | Mar-31-16 | Mar-31-15 |
| Revenues | 1,658,863 | 1,527,283 | 1,502,052 | 3,856,312 | 4,406,199 | 3,164,146 | 4,437,202 | 5,953,417 |
| Revenue growth | 8.6% | 1.7% | -61.0% | -12.5% | 39.3% | -28.7% | -25.5% | 27.3% |
| Cost of goods sold | 1,542,390 | 1,529,351 | 1,525,678 | 1,450,543 | 1,434,667 | 1,410,543 | 1,435,412 | 1,362,859 |
| Gross profit | 116,473 | -2,068 | -23,626 | 2,405,769 | 2,971,532 | 1,753,603 | 3,001,790 | 4,590,558 |
| Gross margin | 7.0% | -0.1% | -1.6% | 62.4% | 67.4% | 55.4% | 67.7% | 77.1% |
| Selling, general and administrative | | | | | | | | 170,163 |
| General and administrative | 152,920 | 150,327 | 158,417 | 152,922 | 149,914 | 147,155 | 150,168 | 115,451 |
| EBITA | 774,507 | 1,972,759 | 466,012 | 959,778 | 1,709,518 | 65,014 | 2,223,661 | 72,996 |
| EBITA margin | 46.7% | 129.2% | 31.0% | 24.9% | 38.8% | 2.1% | 50.1% | 1.2% |
| Amortization of intangibles | 261,026 | 250,106 | 237,328 | 235,083 | 234,376 | 227,942 | 237,342 | 222,353 |
| EBIT | 513,481 | 1,722,653 | 228,684 | 724,695 | 1,475,142 | -162,928 | 1,986,319 | -149,357 |
| EBIT margin | 31.0% | 112.8% | 15.2% | 18.8% | 33.5% | -5.1% | 44.8% | -2.5% |
| Pre-tax income | -58,727 | 1,608,342 | 433,220 | 870,842 | 1,661,819 | 272,543 | 1,162,670 | 2,262,656 |
| Income taxes | -14,511 | 444,948 | 114,505 | 133,237 | 407,823 | 94,453 | 369,432 | 666,020 |
| Tax rate | 24.7% | 27.7% | 26.4% | 15.3% | 24.5% | 34.7% | 31.8% | 29.4% |
| Net income | -83,320 | 1,117,298 | 305,955 | 718,645 | 1,228,160 | 202,680 | 802,332 | 1,522,157 |
| Net margin | -5.0% | 73.2% | 20.4% | 18.6% | 27.9% | 6.4% | 18.1% | 25.6% |
| |
| Diluted EPS | ($6.51) | $86.88 | $23.69 | $55.03 | $92.39 | $14.92 | $57.71 | $107.67 |
| Shares outstanding (diluted) | 12,798 | 12,860 | 12,913 | 13,059 | 13,293 | 13,585 | 13,903 | 14,138 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|